Following the COMPASS: Antithrombotic Prescription Trends in Patients with Symptomatic Peripheral Arterial Disease following Revascularization

The Vascular Outcomes Study of aspirin (ASA) Along with Rivaroxaban in Endovascular or Surgical Limb Revascularization for peripheral artery disease (PAD) trial demonstrated the superiority of ASA and low-dose rivaroxaban (Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of vascular surgery 2024-09, Vol.106, p.341-349
Hauptverfasser:	Elzawy, George, Chan, Joyce, Eisenberg, Naomi, Roche-Nagle, Graham
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!